Valproic	B:C0042291
acid	I:C0042291
enhances	O
the	O
neural	O
differentiation	I:C2755962
of	O
human	O
placenta	O
derived	O
-	O
mesenchymal	O
stem	I:C1257975
cells	I:C1257975
in	O
vitro	O
.	O

Valproic	O
acid	I:C0042291
enhances	O
the	O
neural	B:C2755962
differentiation	I:C2755962
of	O
human	O
placenta	O
derived	O
-	O
mesenchymal	O
stem	I:C1257975
cells	I:C1257975
in	O
vitro	O
.	O

Valproic	O
acid	I:C0042291
enhances	O
the	O
neural	O
differentiation	I:C2755962
of	O
human	B:C0086418
placenta	O
derived	O
-	O
mesenchymal	O
stem	I:C1257975
cells	I:C1257975
in	O
vitro	O
.	O

Valproic	O
acid	I:C0042291
enhances	O
the	O
neural	O
differentiation	I:C2755962
of	O
human	O
placenta	B:C0032043
derived	O
-	O
mesenchymal	O
stem	I:C1257975
cells	I:C1257975
in	O
vitro	O
.	O

Valproic	O
acid	I:C0042291
enhances	O
the	O
neural	O
differentiation	I:C2755962
of	O
human	O
placenta	O
derived	O
-	O
mesenchymal	B:C1257975
stem	I:C1257975
cells	I:C1257975
in	O
vitro	O
.	O

Mesenchymal	B:C1257975
stem	I:C1257975
cells	I:C1257975
(	O
Mesenchymal	O
stem	I:C1257975
cells	I:C1257975
)	O
are	O
known	O
to	O
express	O
a	O
wide	O
range	O
of	O
markers	O
belonging	O
to	O
all	O
the	O
three	O
lineages	O
:	O
mesodermal	O
,	O
ectodermal	O
and	O
endodermal	O
.	O

Mesenchymal	O
stem	I:C1257975
cells	I:C1257975
(	O
Mesenchymal	B:C1257975
stem	I:C1257975
cells	I:C1257975
)	O
are	O
known	O
to	O
express	O
a	O
wide	O
range	O
of	O
markers	O
belonging	O
to	O
all	O
the	O
three	O
lineages	O
:	O
mesodermal	O
,	O
ectodermal	O
and	O
endodermal	O
.	O

Mesenchymal	O
stem	I:C1257975
cells	I:C1257975
(	O
Mesenchymal	O
stem	I:C1257975
cells	I:C1257975
)	O
are	O
known	O
to	O
express	O
a	O
wide	O
range	O
of	O
markers	B:C0005516
belonging	O
to	O
all	O
the	O
three	O
lineages	O
:	O
mesodermal	O
,	O
ectodermal	O
and	O
endodermal	O
.	O

Mesenchymal	O
stem	I:C1257975
cells	I:C1257975
(	O
Mesenchymal	O
stem	I:C1257975
cells	I:C1257975
)	O
are	O
known	O
to	O
express	O
a	O
wide	O
range	O
of	O
markers	O
belonging	O
to	O
all	O
the	O
three	O
lineages	O
:	O
mesodermal	O
,	O
ectodermal	B:C0521458
and	O
endodermal	O
.	O

Therefore	O
,	O
the	O
possibility	O
of	O
their	O
transdifferentiation	B:C2610414
towards	O
a	O
neural	O
lineage	O
has	O
been	O
an	O
aspect	O
of	O
active	O
research	O
.	O

In	O
the	O
present	O
study	O
,	O
Mesenchymal	B:C1257975
stem	I:C1257975
cells	I:C1257975
were	O
isolated	O
from	O
human	O
placental	I:C0694695
tissue	I:C0694695
(	O
P	O
-	O
MSC	O
)	O
and	O
subjected	O
them	O
to	O
neural	O
differentiation	I:C2755962
.	O

In	O
the	O
present	O
study	O
,	O
Mesenchymal	O
stem	I:C1257975
cells	I:C1257975
were	O
isolated	O
from	O
human	B:C0694695
placental	I:C0694695
tissue	I:C0694695
(	O
P	O
-	O
MSC	O
)	O
and	O
subjected	O
them	O
to	O
neural	O
differentiation	I:C2755962
.	O

In	O
the	O
present	O
study	O
,	O
Mesenchymal	O
stem	I:C1257975
cells	I:C1257975
were	O
isolated	O
from	O
human	O
placental	I:C0694695
tissue	I:C0694695
(	O
P	B:C0694695
-	O
MSC	O
)	O
and	O
subjected	O
them	O
to	O
neural	O
differentiation	I:C2755962
.	O

In	O
the	O
present	O
study	O
,	O
Mesenchymal	O
stem	I:C1257975
cells	I:C1257975
were	O
isolated	O
from	O
human	O
placental	I:C0694695
tissue	I:C0694695
(	O
P	O
-	O
MSC	B:C1257975
)	O
and	O
subjected	O
them	O
to	O
neural	O
differentiation	I:C2755962
.	O

In	O
the	O
present	O
study	O
,	O
Mesenchymal	O
stem	I:C1257975
cells	I:C1257975
were	O
isolated	O
from	O
human	O
placental	I:C0694695
tissue	I:C0694695
(	O
P	O
-	O
MSC	O
)	O
and	O
subjected	O
them	O
to	O
neural	B:C2755962
differentiation	I:C2755962
.	O

It	O
was	O
found	O
that	O
the	O
P	B:C0694695
-	O
Mesenchymal	O
stem	I:C1257975
cells	I:C1257975
differentiated	O
towards	O
neural	O
lineage	O
in	O
appropriate	O
differentiation	O
conditions	O
.	O

It	O
was	O
found	O
that	O
the	O
P	O
-	O
Mesenchymal	B:C1257975
stem	I:C1257975
cells	I:C1257975
differentiated	O
towards	O
neural	O
lineage	O
in	O
appropriate	O
differentiation	O
conditions	O
.	O

It	O
was	O
found	O
that	O
the	O
P	O
-	O
Mesenchymal	O
stem	I:C1257975
cells	I:C1257975
differentiated	B:C3156550
towards	O
neural	O
lineage	O
in	O
appropriate	O
differentiation	O
conditions	O
.	O

However	O
,	O
when	O
a	O
histone	B:C1512474
deacetylase	I:C1512474
(	I:C1512474
HDAC	I:C1512474
)	I:C1512474
inhibitor	I:C1512474
-	O
valproic	O
acid	I:C0042291
(	O
valproic	O
acid	I:C0042291
)	O
-	O
was	O
incorporated	O
in	O
the	O
medium	O
,	O
there	O
was	O
a	O
further	O
increase	O
in	O
their	O
neural	O
differentiation	I:C2755962
potential	I:C2755962
.	O

However	O
,	O
when	O
a	O
histone	O
deacetylase	I:C1512474
(	I:C1512474
HDAC	I:C1512474
)	I:C1512474
inhibitor	I:C1512474
-	O
valproic	B:C0042291
acid	I:C0042291
(	O
valproic	O
acid	I:C0042291
)	O
-	O
was	O
incorporated	O
in	O
the	O
medium	O
,	O
there	O
was	O
a	O
further	O
increase	O
in	O
their	O
neural	O
differentiation	I:C2755962
potential	I:C2755962
.	O

However	O
,	O
when	O
a	O
histone	O
deacetylase	I:C1512474
(	I:C1512474
HDAC	I:C1512474
)	I:C1512474
inhibitor	I:C1512474
-	O
valproic	O
acid	I:C0042291
(	O
valproic	B:C0042291
acid	I:C0042291
)	O
-	O
was	O
incorporated	O
in	O
the	O
medium	O
,	O
there	O
was	O
a	O
further	O
increase	O
in	O
their	O
neural	O
differentiation	I:C2755962
potential	I:C2755962
.	O

However	O
,	O
when	O
a	O
histone	O
deacetylase	I:C1512474
(	I:C1512474
HDAC	I:C1512474
)	I:C1512474
inhibitor	I:C1512474
-	O
valproic	O
acid	I:C0042291
(	O
valproic	O
acid	I:C0042291
)	O
-	O
was	O
incorporated	O
in	O
the	O
medium	B:C0010454
,	O
there	O
was	O
a	O
further	O
increase	O
in	O
their	O
neural	O
differentiation	I:C2755962
potential	I:C2755962
.	O

However	O
,	O
when	O
a	O
histone	O
deacetylase	I:C1512474
(	I:C1512474
HDAC	I:C1512474
)	I:C1512474
inhibitor	I:C1512474
-	O
valproic	O
acid	I:C0042291
(	O
valproic	O
acid	I:C0042291
)	O
-	O
was	O
incorporated	O
in	O
the	O
medium	O
,	O
there	O
was	O
a	O
further	O
increase	O
in	O
their	O
neural	B:C2755962
differentiation	I:C2755962
potential	I:C2755962
.	O

The	O
increase	O
in	O
the	O
number	O
of	O
neurites	B:C0085103
and	O
neural	O
lineage	I:C0443981
specific	I:C0443981
markers	I:C0443981
was	O
notable	O
.	O

The	O
increase	O
in	O
the	O
number	O
of	O
neurites	O
and	O
neural	B:C0443981
lineage	I:C0443981
specific	I:C0443981
markers	I:C0443981
was	O
notable	O
.	O

The	O
valproic	B:C0042291
acid	I:C0042291
-	O
treated	O
cells	O
showed	O
a	O
significantly	O
elevated	I:C1156296
membrane	I:C1156296
potential	I:C1156296
compared	O
with	O
the	O
cells	O
grown	I:C0007589
in	I:C0007589
only	I:C0007589
differentiation	I:C0007589
medium	I:C0007589
.	O

The	O
valproic	O
acid	I:C0042291
-	O
treated	O
cells	B:C1257975
showed	O
a	O
significantly	O
elevated	I:C1156296
membrane	I:C1156296
potential	I:C1156296
compared	O
with	O
the	O
cells	O
grown	I:C0007589
in	I:C0007589
only	I:C0007589
differentiation	I:C0007589
medium	I:C0007589
.	O

The	O
valproic	O
acid	I:C0042291
-	O
treated	O
cells	O
showed	O
a	O
significantly	B:C1156296
elevated	I:C1156296
membrane	I:C1156296
potential	I:C1156296
compared	O
with	O
the	O
cells	O
grown	I:C0007589
in	I:C0007589
only	I:C0007589
differentiation	I:C0007589
medium	I:C0007589
.	O

The	O
valproic	O
acid	I:C0042291
-	O
treated	O
cells	O
showed	O
a	O
significantly	O
elevated	I:C1156296
membrane	I:C1156296
potential	I:C1156296
compared	O
with	O
the	O
cells	B:C0007589
grown	I:C0007589
in	I:C0007589
only	I:C0007589
differentiation	I:C0007589
medium	I:C0007589
.	O

When	O
the	O
molecular	O
mechanism	O
was	O
studied	O
,	O
the	O
enhancement	O
in	O
the	O
neuronal	B:C1658579
lineage	I:C1658579
specification	I:C1658579
was	O
caused	O
by	O
the	O
inhibition	O
of	I:C2244568
bone	O
morphogenetic	I:C0527443
protein	I:C0527443
(	I:C0527443
BMP	I:C0527443
)	I:C0527443
2	I:C0527443
and	O
an	O
increase	O
in	O
BMP4	O
under	O
both	O
conditions	O
.	O

When	O
the	O
molecular	O
mechanism	O
was	O
studied	O
,	O
the	O
enhancement	O
in	O
the	O
neuronal	O
lineage	I:C1658579
specification	I:C1658579
was	O
caused	O
by	O
the	O
inhibition	B:C2244568
of	I:C2244568
bone	O
morphogenetic	I:C0527443
protein	I:C0527443
(	I:C0527443
BMP	I:C0527443
)	I:C0527443
2	I:C0527443
and	O
an	O
increase	O
in	O
BMP4	O
under	O
both	O
conditions	O
.	O

When	O
the	O
molecular	O
mechanism	O
was	O
studied	O
,	O
the	O
enhancement	O
in	O
the	O
neuronal	O
lineage	I:C1658579
specification	I:C1658579
was	O
caused	O
by	O
the	O
inhibition	O
of	I:C2244568
bone	B:C0527443
morphogenetic	I:C0527443
protein	I:C0527443
(	I:C0527443
BMP	I:C0527443
)	I:C0527443
2	I:C0527443
and	O
an	O
increase	O
in	O
BMP4	O
under	O
both	O
conditions	O
.	O

When	O
the	O
molecular	O
mechanism	O
was	O
studied	O
,	O
the	O
enhancement	O
in	O
the	O
neuronal	O
lineage	I:C1658579
specification	I:C1658579
was	O
caused	O
by	O
the	O
inhibition	O
of	I:C2244568
bone	O
morphogenetic	I:C0527443
protein	I:C0527443
(	I:C0527443
BMP	I:C0527443
)	I:C0527443
2	I:C0527443
and	O
an	O
increase	O
in	O
BMP4	B:C0530979
under	O
both	O
conditions	O
.	O

The	O
target	O
of	O
valproic	B:C0042291
acid	I:C0042291
(	O
HDAC2	O
)	O
was	O
reduced	O
in	O
the	O
valproic	O
acid	I:C0042291
set	O
,	O
whereas	O
HDAC1	O
remained	O
unchanged	O
.	O

The	O
target	O
of	O
valproic	O
acid	I:C0042291
(	O
HDAC2	B:C2713652
)	O
was	O
reduced	O
in	O
the	O
valproic	O
acid	I:C0042291
set	O
,	O
whereas	O
HDAC1	O
remained	O
unchanged	O
.	O

The	O
target	O
of	O
valproic	O
acid	I:C0042291
(	O
HDAC2	O
)	O
was	O
reduced	O
in	O
the	O
valproic	B:C0042291
acid	I:C0042291
set	O
,	O
whereas	O
HDAC1	O
remained	O
unchanged	O
.	O

The	O
target	O
of	O
valproic	O
acid	I:C0042291
(	O
HDAC2	O
)	O
was	O
reduced	O
in	O
the	O
valproic	O
acid	I:C0042291
set	O
,	O
whereas	O
HDAC1	B:C1334032
remained	O
unchanged	O
.	O

Concurrent	O
reduction	B:C1155515
in	I:C1155515
the	I:C1155515
levels	I:C1155515
of	I:C1155515
Stat3	I:C1155515
was	O
observed	O
,	O
leading	O
to	O
an	O
upregulation	O
of	I:C3894267
Î²III	I:C3894267
tubulin	I:C3894267
,	O
which	O
is	O
a	O
neuronal	O
lineage	I:C0443981
-	I:C0443981
specific	I:C0443981
marker	I:C0443981
.	O

Concurrent	O
reduction	O
in	I:C1155515
the	I:C1155515
levels	I:C1155515
of	I:C1155515
Stat3	I:C1155515
was	O
observed	O
,	O
leading	O
to	O
an	O
upregulation	B:C3894267
of	I:C3894267
Î²III	I:C3894267
tubulin	I:C3894267
,	O
which	O
is	O
a	O
neuronal	O
lineage	I:C0443981
-	I:C0443981
specific	I:C0443981
marker	I:C0443981
.	O

Concurrent	O
reduction	O
in	I:C1155515
the	I:C1155515
levels	I:C1155515
of	I:C1155515
Stat3	I:C1155515
was	O
observed	O
,	O
leading	O
to	O
an	O
upregulation	O
of	I:C3894267
Î²III	I:C3894267
tubulin	I:C3894267
,	O
which	O
is	O
a	O
neuronal	B:C0443981
lineage	I:C0443981
-	I:C0443981
specific	I:C0443981
marker	I:C0443981
.	O

The	O
components	O
of	O
Notch	B:C1155452
signalling	I:C1155452
(	O
i.e.	O
decreased	O
notch	I:C0949469
1	I:C0949469
and	O
increased	O
notch	I:C0949479
3	I:C0949479
)	O
also	O
supported	O
differentiation	O
towards	O
the	O
neuronal	O
lineage	I:C1658579
.	O

The	O
components	O
of	O
Notch	O
signalling	I:C1155452
(	O
i.e.	O
decreased	B:C0949469
notch	I:C0949469
1	I:C0949469
and	O
increased	O
notch	I:C0949479
3	I:C0949479
)	O
also	O
supported	O
differentiation	O
towards	O
the	O
neuronal	O
lineage	I:C1658579
.	O

The	O
components	O
of	O
Notch	O
signalling	I:C1155452
(	O
i.e.	O
decreased	O
notch	I:C0949469
1	I:C0949469
and	O
increased	B:C0949479
notch	I:C0949479
3	I:C0949479
)	O
also	O
supported	O
differentiation	O
towards	O
the	O
neuronal	O
lineage	I:C1658579
.	O

The	O
components	O
of	O
Notch	O
signalling	I:C1155452
(	O
i.e.	O
decreased	O
notch	I:C0949469
1	I:C0949469
and	O
increased	O
notch	I:C0949479
3	I:C0949479
)	O
also	O
supported	O
differentiation	B:C2755962
towards	O
the	O
neuronal	O
lineage	I:C1658579
.	O

The	O
components	O
of	O
Notch	O
signalling	I:C1155452
(	O
i.e.	O
decreased	O
notch	I:C0949469
1	I:C0949469
and	O
increased	O
notch	I:C0949479
3	I:C0949479
)	O
also	O
supported	O
differentiation	O
towards	O
the	O
neuronal	B:C1658579
lineage	I:C1658579
.	O

Thus	O
,	O
the	O
valproic	B:C0042291
acid	I:C0042291
treated	O
P	O
-	O
Mesenchymal	O
stem	I:C1257975
cells	I:C1257975
can	O
serve	O
as	O
an	O
alternative	O
source	O
for	O
deriving	O
neural	O
cells	I:C0027882
for	O
use	O
in	O
both	O
research	O
and	O
in	O
clinics	O
.	O

Thus	O
,	O
the	O
valproic	O
acid	I:C0042291
treated	O
P	B:C0694695
-	O
Mesenchymal	O
stem	I:C1257975
cells	I:C1257975
can	O
serve	O
as	O
an	O
alternative	O
source	O
for	O
deriving	O
neural	O
cells	I:C0027882
for	O
use	O
in	O
both	O
research	O
and	O
in	O
clinics	O
.	O

Thus	O
,	O
the	O
valproic	O
acid	I:C0042291
treated	O
P	O
-	O
Mesenchymal	B:C1257975
stem	I:C1257975
cells	I:C1257975
can	O
serve	O
as	O
an	O
alternative	O
source	O
for	O
deriving	O
neural	O
cells	I:C0027882
for	O
use	O
in	O
both	O
research	O
and	O
in	O
clinics	O
.	O

Thus	O
,	O
the	O
valproic	O
acid	I:C0042291
treated	O
P	O
-	O
Mesenchymal	O
stem	I:C1257975
cells	I:C1257975
can	O
serve	O
as	O
an	O
alternative	O
source	O
for	O
deriving	O
neural	B:C0027882
cells	I:C0027882
for	O
use	O
in	O
both	O
research	O
and	O
in	O
clinics	O
.	O

Thus	O
,	O
the	O
valproic	O
acid	I:C0042291
treated	O
P	O
-	O
Mesenchymal	O
stem	I:C1257975
cells	I:C1257975
can	O
serve	O
as	O
an	O
alternative	O
source	O
for	O
deriving	O
neural	O
cells	I:C0027882
for	O
use	O
in	O
both	O
research	B:C0035168
and	O
in	O
clinics	O
.	O

Thus	O
,	O
the	O
valproic	O
acid	I:C0042291
treated	O
P	O
-	O
Mesenchymal	O
stem	I:C1257975
cells	I:C1257975
can	O
serve	O
as	O
an	O
alternative	O
source	O
for	O
deriving	O
neural	O
cells	I:C0027882
for	O
use	O
in	O
both	O
research	O
and	O
in	O
clinics	B:C0442592
.	O

